Gamma Holding

Gamma Biosciences is a life sciences platform company established by KKR to acquire and build a portfolio of advanced technologies for the biopharmaceutical industry. The company focuses on the bioprocessing sector, specifically targeting bottlenecks in the manufacturing of advanced therapies such as cell and gene therapies, vaccines, and biologics. Its portfolio includes specialized businesses like Astrea Bioseparations, which provides downstream processing and purification tools, and Nanopareil, a developer of high-performance membrane technology. By integrating these high-growth technology providers, Gamma Biosciences offers an end-to-end solution for drug developers to scale their production and improve purification processes. The company aims to accelerate the delivery of next-generation medicines through its suite of innovative tools and services.